Interventional Orthobiologics Foundation

That's a wrap on the 2025 #IOFMAX Experience! As you can see in the video below, over the past decade our annual conference has grown to be the largest orthobiologics conference in the U.S. This year marked our?biggest conference yet, bringing together world-class researchers, clinicians, and industry leaders to shape the future of regenerative medicine. Thank you?to our attendees, speakers, and exhibitors for making this milestone year unforgettable. Here’s to the next ten years of progress—see you in 2026!

The?10th anniversary?of the?Interventional Orthobiologics Foundation (IOF) MAX Experience?was the biggest yet!?DataBiologics?was at the center of it—here are some key takeaways: ?? Biologics for Low Back Pain?–?Mary A. Ambach MD RMSK?shared DataBiologics registry data on?intradiscal orthobiologics, showing significant pain relief & functional gains. ?? Platelet Dosing & PRP Efficacy?–?William A. Berrigan, MD, RMSK presented findings on?PRP doses >10B platelets, improving function & chondroprotection in knee OA. ?? PRP Dosing Lab?–?Jérémy Magalon, William Berrigan, and Prof. Himanshu Bansal?explored?optimal PRP preparation & clinical applications?with PLYMOUTH MEDICAL. ?? MFAT for Shoulder OA?–?Ariana De Mers?shared?registry data?supporting MFAT’s role in treating?rotator cuff pathology & OA?with sustained benefits at?24 months. ?? Mastering Patient Engagement?–?Don Buford, MD?emphasized that?trust, reputation & follow-ups?are key to patient outcomes & practice growth. ?? Biologics in Veterinary Medicine?–?Lisa Fortier?discussed?emerging equine treatments, urging a closer look at?monocytes’ role in tissue repair. ?? Biologic Association Updates?–?Shane Shapiro?highlighted how the BA is creating?collaborations among societies and updates on the BARB biorepository. ?? DataBiologics Top Performer Awards?– Recognizing providers achieving?exceptional real-world outcomes?in?blood-derived orthobiologics. A huge?thank you?to Jillian Abramson, MBA and Leisha Gravley for hosting an?incredible conference! https://lnkd.in/gJZ73_ij

IOF's social media director here—taking a moment to celebrate the incredible Jillian Abramson, MBA and Leisha Gravley on Employee Appreciation Day! This incredible duo works tirelessly to advance IOF's mission every day. Their dedication and hard work can't be overstated. Thank you, Jillian and Leisha!

"The rapid literature shift toward orthobiologics urges an update in societies' guidelines to align with the new body of evidence on knee OA treatments." Review: https://lnkd.in/gHdaGxru

The?IOF MAX Experience?may be over, but the learning doesn’t stop here! IOF offers our structured curriculum taught by expert faculty year-round. Build skills and confidence in a variety of orthobiologic injection techniques. We have several courses across the country in the next few months. View the full schedule and register: https://bit.ly/2Y0lWjj

We were thrilled to welcome Adam Tenforde, MD to provide an update on the latest advances in shockwave therapy at the #IOFMAX Experience. A few key takeaways from his review of an international Delphi statement: -Shockwave NOT recommended for high-grade and full-thickness tendon tears -Do not use anesthesia -Combine ESWT with physical therapy -Treat 1-2 weeks apart for 3-5 sessions -Combine the use of focus and radial devices when available -No consensus to combine ESWT with orthobiologics

That’s a wrap on another great session at the #IOFMAX Experience! Reza Jazayeri, MD covered?metabolic optimization for orthobiologics, highlighting the critical role of nutrition in recovery. He explored several trending topics, including how targeted amino acid supplementation can reduce muscle loss, enhance healing, and improve outcomes. Integrating metabolic strategies alongside orthobiologics has the potential to transform patient care.?

The?compliance panel?is always one of the most highly anticipated sessions at #IOFMAX, and this year’s discussion provided critical insights into the evolving regulatory landscape. Our expert panel tackled pressing compliance challenges, including: ?? The FDA’s inconsistent enforcement?of orthobiologic regulations and its broader implications for physicians and patients. ?? The impact of recent Supreme Court rulings, particularly the end of?Chevron deference, on how regulatory decisions will be interpreted moving forward. ?? The debate over federal vs. state jurisdiction, and whether states should take on a greater role in overseeing orthobiologic treatments. ?? The complexities of cell banking and cross-border access, including legal hurdles for patients seeking to use their own stored biologics. Thank you to our panelists for sharing your expertise: Andrew S. Ittleman, Rikin Patel, DO and Scott Bruder, MD, PhD.

Please join us in thanking?IOF President Wayne McIlwraith, DVM, PhD, for his exceptional leadership over the past year. Under his guidance, IOF has experienced significant membership growth and exciting new developments that continue to advance our mission. Thank you, Dr. McIlwraith, for your dedication and lasting impact on IOF.

We want to take a moment to recognize the outstanding group of experts who shared the latest research on orthobiologics for knee OA this morning at the #IOFMAX Experience. Their insights and expertise continue to advance the field—thank you for your contributions Dr Ignacio Dallo, Dr. philippe hernigou, Dr Mandy Zhang, Prof. Jérémy Magalon, Prof. Himanshu Bansal, Michael Baria, MD MBA and Zach Bailowitz, MD, RMSK. We also want to give a big shoutout to our emcees, Don Buford, MD and Shounuck Patel, DO for moderating this panel and many others this weekend!